Company intelligence / Profile preview
Tetra Pharm Technologies
Copenhagen/Hillerød*, Capital Region of Denmark/Copenhagen area, Denmarktetrapharm.eu ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Tetra Pharm Technologies has advanced its lead candidate for chronic pain into Phase I trials. Other programs targeting obesity/appetite suppression and neurological/psychiatric conditions remain in preclinical development. The company leverages the endocannabinoid system for novel CNS and immune-related therapeutics. Recent collaborations aim to accelerate drug discovery using AI-driven approaches.
- Therapeutic areas
- EndocrinologyPsychiatryNeurology
- Modalities
- Small molecules (notably cannabinoid-based therapies)Chemical drugs
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
Kvantify ApS – partnership to accelerate ECS-targeted drug discovery using AI/machine learning approachesGlysious – collaboration on transdermal delivery of ECS-targeting compounds
Beyond the preview
Go deeper on Tetra Pharm Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tetra Pharm Technologies.